Stand up for the facts!
Our only agenda is to publish the truth so you can be an informed participant in democracy.
We need your help.
I would like to contribute
California regularly portrays itself as a national trendsetter on political issues, and Gov. Gavin Newsom is claiming that title on prescription drugs.
Newsom has a plan to take on the drug industry, and at an April 17 news conference in Southern California, he declared that two other governors already want to join his effort.
"California is leading the nation in holding drug companies accountable and fighting prescription drug prices," Newsom said via a press release that day, marking his 100th full day in office.
There’s no question the Democratic governor is aggressively taking on the pharmaceutical industry — vowing to leverage his state’s purchasing power to extract lower prices, and bluntly telling drugmakers that taxpayers are tired of being "screwed."
But Newsom’s claim that California leads the nation on this issue prompted us to ask: Is that really the case?
What is Newsom doing about prescription drugs?
Newsom marked his first day in office, Jan. 7, with a direct message to the pharmaceutical industry: The nation’s most populous state is fed up with the meteoric rise in prescription drug prices.
He signed an executive order directing the state to negotiate drug prices for the roughly 13 million enrollees of Medi-Cal, the country’s largest Medicaid program that serves low-income residents, by 2021. And he ordered his administration to study how state agencies could band together and buy prescription drugs in bulk.
With the state buying drugs for all Medi-Cal enrollees and state entities, Newsom argues that California will leverage its purchasing power as the third-largest buyer in the country to demand lower prices from drugmakers. Eventually, Newsom envisions private purchasers — including small businesses, health plans and self-insured Californians — taking part.
Newsom has said several times he hopes this collaboration can be a model for the rest of the country.
Newsom traveled to Downey, Calif., last week to announce that Los Angeles County would join California’s bulk purchasing pool, a move intended to show that others are eager to join his initiative.
How do California’s efforts on prescription drugs compare with those of other states?
We interviewed five health care experts who commended Newsom for his focus on prescription drugs, but each noted that he is not the only lawmaker tackling the issue.
"Is California a leader? Yes. Is it the leader?" asked Edwin Park, a research professor at Georgetown University’s Center for Children and Families. "That’s not doing an assessment of what all the other states are doing."
A number of states in recent years have enacted laws to regulate pharmacy benefit managers, the so-called middlemen who negotiate with drugmakers; impose drug price transparency rules; outlaw "gag clauses" that prevent pharmacists from telling consumers about cheaper drug alternatives; and authorize the importation of drugs from Canada.
At least 28 states and the District of Columbia already participate in multistate purchasing pools — joining forces to get bigger discounts for their Medicaid programs or state employees. The Northwest Prescription Drug Consortium, formed by Oregon and Washington in 2006, invites state and local government agencies, businesses, labor unions and uninsured consumers to voluntarily pool their purchasing power.
Roughly 1.1 million people are represented by the consortium, either as individuals or through public and private entities such as the Washington State Department of Corrections, Washington’s Medicaid program and SAIF Corp.
"Other states are actively looking at us as a partner," said Trevor Douglass, director of the Oregon Prescription Drug Program.
Earlier this month, Maryland lawmakers passed legislation that would create the nation’s first prescription drug affordability board, which, if signed by Republican Gov. Larry Hogan, would let the state cap certain drug prices.
"There’s extraordinary activity" on prescription drug prices, said Trish Riley, executive director of the National Academy for State Health Policy, which tracks bills in state legislatures around the country. "Hundreds of bills were introduced this year."
What makes California’s effort novel, Newsom spokesman Nathan Click said, is the mandatory inclusion of all state agencies and the Medi-Cal program — which he said would make it the largest purchaser of drugs after Medicare and the Department of Veterans Affairs. Programs in other states are more limited, and some are voluntary.
Health care experts agreed that California’s size by default makes it a national leader on the health care front, not the national leader. But if California is successful, they say, it could lower the price of drugs nationally.
Newsom said "California is leading the nation in holding drug companies accountable and fighting prescription drug prices."
States across the county are addressing the rising cost of prescription drugs in a variety of ways. California is not the only, or the first, one.
The scope of what Newsom is attempting could bring down drug prices for California residents, and possibly residents in other states that join the effort. But Newsom’s sweeping plan is still in its infancy with many details pending, so it’s too soon to gauge success.
We rate the claim HALF TRUE.
This fact check was reported and edited by Kaiser Health News. PolitiFact and KHN are partnering to fact-check claims about health care.
Gov. Gavin Newsom’s Executive Order on prescription drugs, Jan. 7, 2019
California Gov. Gavin Newsom remarks at news conference on prescription drugs, April 17, 2019
California Gov. Gavin Newsom, quote in press release, April 17, 2019
California Gov. Gavin Newsom, news release Jan. 7, 2019, announcing prescription drug executive order
Phone interview with Nathan Click, spokesman for Gov. Gavin Newsom, April 18, 2019
Phone interview with Edwin Park, a research professor at Georgetown University Health Policy Institute’s Center for Children and Families, April 18, 2019
Phone interview with Trish Riley, executive director, National Academy for State Health Policy, April 19, 2019
Phone interview with Erin Fuse Brown, associate professor of law at the Center for Law, Health and Society at Georgia State University, April 18, 2019
Phone interview with Jaime King, associate dean, UC Hastings College of the Law, April 18, 2019
Phone interview with Trevor Douglass, director of the Oregon Prescription Drug Program, April 19, 2019
The Northwest Prescription Drug Consortium, visited April 18, 2019
"How to Strengthen the Medicaid Drug Rebate Program to Address Rising Medicaid Prescription Drug Costs," by Edwin Park, January 2019.
Read About Our Process
In a world of wild talk and fake news, help us stand up for the facts.